These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 6132540

  • 1. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1).
    Schmidt S, Süss J, Oehring H, Schmidt J.
    Acta Virol; 1982 Dec; 26(6):466-73. PubMed ID: 6132540
    [Abstract] [Full Text] [Related]

  • 2. Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years.
    Nabeshima S, Kashiwagi K, Murata M, Kanamoto Y, Furusyo N, Hayashi J.
    J Med Virol; 2007 Mar; 79(3):320-5. PubMed ID: 17245715
    [Abstract] [Full Text] [Related]

  • 3. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [Abstract] [Full Text] [Related]

  • 4. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA, Carter DM, Daniluk S, Toapanta FR, Ahmad A, Gavrilov V, Massare M, Pushko P, Mytle N, Rowe T, Smith G, Ross TM.
    Vaccine; 2007 May 10; 25(19):3871-8. PubMed ID: 17337102
    [Abstract] [Full Text] [Related]

  • 5. Immune response to influenza vaccination in community-dwelling Chinese elderly persons.
    Hui SL, Chu LW, Peiris JS, Chan KH, Chu D, Tsui W.
    Vaccine; 2006 Jun 19; 24(25):5371-80. PubMed ID: 16713661
    [Abstract] [Full Text] [Related]

  • 6. Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial.
    Roman F, Vaman T, Gerlach B, Markendorf A, Gillard P, Devaster JM.
    Vaccine; 2010 Feb 17; 28(7):1740-5. PubMed ID: 20034605
    [Abstract] [Full Text] [Related]

  • 7. Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response.
    Oren S, Mandelboim M, Braun-Moscovici Y, Paran D, Ablin J, Litinsky I, Comaneshter D, Levartovsky D, Mendelson E, Azar R, Wigler I, Balbir-Gurman A, Caspi D, Elkayam O.
    Ann Rheum Dis; 2008 Jul 17; 67(7):937-41. PubMed ID: 17981914
    [Abstract] [Full Text] [Related]

  • 8. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J.
    Virology; 2008 Oct 25; 380(2):412-20. PubMed ID: 18786689
    [Abstract] [Full Text] [Related]

  • 9. Characteristics of cell-mediated immunity after oral administration of a live influenza vaccine.
    Unanov SS, Yuminova NV, Akopova II.
    Acta Virol; 1982 Dec 25; 26(6):474-80. PubMed ID: 6132541
    [Abstract] [Full Text] [Related]

  • 10. Comparison of one- and two-dose regimens of influenza vaccine for elderly men.
    Levine M, Beattie BL, McLean DM.
    CMAJ; 1987 Oct 15; 137(8):722-6. PubMed ID: 3651943
    [Abstract] [Full Text] [Related]

  • 11. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity.
    Clark A, Potter CW, Jennings R, Nicholl JP, Langrick AF, Schild GC, Wood JM, Tyrrell DA.
    J Hyg (Lond); 1983 Jun 15; 90(3):361-70. PubMed ID: 6863910
    [Abstract] [Full Text] [Related]

  • 12. The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.
    Kitikoon P, Nilubol D, Erickson BJ, Janke BH, Hoover TC, Sornsen SA, Thacker EL.
    Vet Immunol Immunopathol; 2006 Aug 15; 112(3-4):117-28. PubMed ID: 16621020
    [Abstract] [Full Text] [Related]

  • 13. Persistence of influenza serum antibodies in humans following immunization with a bivalent A/Victoria and A/New Jersey vaccine.
    Boucher DW, Contreras G, Furesz J.
    Can Med Assoc J; 1979 Apr 07; 120(7):799-802, 831. PubMed ID: 427686
    [Abstract] [Full Text] [Related]

  • 14. Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers.
    Iorio AM, Camilloni B, Basileo M, Neri M, Lepri E, Spighi M.
    Gerontology; 2007 Apr 07; 53(6):411-8. PubMed ID: 17975317
    [Abstract] [Full Text] [Related]

  • 15. Enumeration of haemagglutinin-specific CD8+ T cells after influenza vaccination using MHC class I peptide tetramers.
    Kosor Krnic E, Gagro A, Drazenovic V, Kuzman I, Jeren T, Cecuk-Jelicic E, Kerhin-Brkljacic V, Gjenero-Margan I, Kaic B, Rakusic S, Sabioncello A, Markotic A, Rabatic S, Mlinaric-Galinovic G, Dekaris D.
    Scand J Immunol; 2008 Jan 07; 67(1):86-94. PubMed ID: 18052968
    [Abstract] [Full Text] [Related]

  • 16. Is there a benefit from an early booster vaccination in the control of equine influenza?
    Heldens JG, van Loon AA, van de Zande S.
    Vet J; 2007 Nov 07; 174(3):592-8. PubMed ID: 17560150
    [Abstract] [Full Text] [Related]

  • 17. Autoantibodies in human sera after vaccination with inactivated influenza vaccine.
    Loza-Tulimowska M, Semkow R, Michalak T, Wilczyński J.
    Acta Virol; 1979 Mar 07; 23(2):159-61. PubMed ID: 39440
    [Abstract] [Full Text] [Related]

  • 18. A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza.
    Kung HC, Huang KC, Kao TM, Lee YC, Chang FY, Wang NC, Liu YC, Lee WS, Liu HJ, Chen CI, Chen CH, Huang LM, Hsieh SM.
    Vaccine; 2010 Oct 21; 28(45):7337-43. PubMed ID: 20817013
    [Abstract] [Full Text] [Related]

  • 19. Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine.
    Greenbaum E, Engelhard D, Levy R, Schlezinger M, Morag A, Zakay-Rones Z.
    Vaccine; 2004 Jun 30; 22(20):2566-77. PubMed ID: 15193382
    [Abstract] [Full Text] [Related]

  • 20. Clinico-immunologic and allergologic studies with the inactivated influenza virus vaccine purified and concentrated by gradient centrifugation.
    Subbotina TI, Tenkova TV, Sidorova LV, Shpilyuk GF, Drinevsky VP, Voitsekhovskaya EM, Konstantinov VK, Sominina AA.
    Acta Virol; 1988 Nov 30; 32(6):494-502. PubMed ID: 2906221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.